Serum Uromodulin May Predict CKD Development
Uromodulin may be a novel predictive serum biomarker.
Uromodulin may be a novel predictive serum biomarker.
Non-metastatic prostate cancer patients are more likely to die from causes other than the disease.
Methylene blue aids observation of the procedure and assessment of drug distribution.
A number of patients referred to my faculty ambulatory clinic at the University of California Irvine have urologic disorders, including some who underwent partial or radical nephrectomy. Many patients do not comprehend the distinction between nephrologist and urologist, and refer to both as “kidney doctor.” I often educate these patients, explaining that a urologist is…
Among hemodialysis patients always or nearly always bothered by itchy skin, 17% did not report their symptoms to a health care provider and 18% used no treatment for the condition.
Use of active surveillance for very low-risk prostate cancer rose from 11.6% of patients in 2010 to 27.3% in 2013, study finds.
Checkpoint inhibitor combination of nivolumab plus ipilimumab improved progression-free and overall survival compared with sunitinib.
Tinnitus is 3-fold more likely to develop in patients with versus without chronic kidney disease, new study shows.
PSA levels of 10 ng/mL or higher in men who have biochemically recurrent PCa after radical prostatectomy and a PSADT less than 12 months are at imminent risk for metastatic disease.
Targeting and treating systolic blood pressure to a lower range was associated with a 14% decreased risk of death, meta-analysis shows.